An Illness Sickening and Killing Dogs in Michigan Is Puzzling Investigators
LANSING, Mich. — State and federal agencies are investigating an unknown illness that’s sickened dogs in northern Michigan and killed at least 30 canines in one county after they exhibited signs of a parvo-like illness.
The Michigan Department of Agriculture and Rural Development said it’s working with local animal control shelters, veterinarians, the Michigan State University’s veterinary laboratory, the U.S. Department of Agriculture and other partners on testing to determine the illness’ cause.
The state agency said “several dogs” have fallen ill with the same symptoms in the st...
Source: TIME: Health - August 24, 2022 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized healthscienceclimate Public Health wire Source Type: news
Mozambique: Mozambique Purchases Over One Million Vaccines Against Foot and Mouth Disease
[AIM] Maputo -- The Mozambique Veterinary Authority intends to import over a million doses of vaccine against foot-and-mouth disease to respond to the outbreak confirmed in the districts of Chifunde, Mar ávia and Moatize, in the central province of Tete. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 23, 2022 Category: African Health Source Type: news
Mozambique: Mozambique Purchases Foot-and-Mouth Vaccines
[AIM] The Mozambique Veterinary Authority is to import over a million doses of vaccine against foot-and-mouth disease in response to the confirmed outbreak in the districts of Chifunde, Maravia, and Moatize, in the central province of Tete. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 23, 2022 Category: African Health Source Type: news
Pfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA Authorization
All COVID-19 vaccines that are used in the U.S. target the same original strain of SARS-CoV-2. But boosters designed to protect against the latest Omicron subvariants could be coming soon.
On Aug. 22, Pfizer-BioNTech submitted a request to the U.S. Food and Drug Administration (FDA) to authorize its Omicron-specific vaccine. The shot targets BA.4 and BA.5, which now account for nearly all new infections in the U.S.
In an announcement, Pfizer-BioNTech requested emergency use authorization for a booster dose of the vaccine, which contains a combination of the genetic material mRNA from the original virus circulating when the...
Source: TIME: Health - August 22, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
News at a glance: Omicron vaccine, colonial-era exploitation, and mapping health equity
IN FOCUS
Scientists rallied outside Canada’s Parliament on 11 August, carrying a 70-meter-long letter with more than 7000 signatures. The letter to lawmakers calls for increases in the stipends paid by graduate student scholarships and postdoctoral fellowships awarded by the Natural Sciences and Engineering Research Council of Canada. “We can’t do science if we can’t pay rent,” one rallygoer’s sign read.
COVID-19
U.K. OKs anti-Omicron vaccine
The United Kingdom this week became the first country to approve an updated COVID-19 booster directed at two different strains o...
Source: ScienceNOW - August 18, 2022 Category: Science Source Type: news
U.S. Offers Extra Monkeypox Vaccine Doses for Gay Pride Events
NEW YORK — The U.S. is setting aside an extra 50,000 doses of monkeypox vaccine for places with upcoming gay pride events, health officials said Thursday.
The number of doses sent to each will be based on factors like the size of the event, how many health workers will be available to give shots, and how many of the attendees are considered at highest risk for catching the virus.
“More shots in arms is how we get the outbreak under control,” Bob Fenton, the White House monkeypox response coordinator, told reporters Thursday. He said the effort is an attempt to “meet people where they are.”
[ti...
Source: TIME: Health - August 18, 2022 Category: Consumer Health News Authors: Mike Stobbe/AP Tags: Uncategorized healthscienceclimate monkeypox Vaccines wire Source Type: news
Ghana: Ghana Targets 'Zero Human Rabies' By 2030
[Ghanaian Times] Ghana would be able to achieve "Zero human rabies deaths by 2030" through mass dog vaccinations, targeting coverage of 70 per cent and above annually, the Head of Veterinary Epidemiology, Dr Yaw Fenteng Danso, has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 16, 2022 Category: African Health Source Type: news
Illumina Helped the World Fight COVID-19. Now, CEO Francis deSouza Has Monkeypox in His Sights
As chief executive of San Diego-based genomic sequencing company Illumina, Francis deSouza feels well-placed to witness the world’s next great scientific transformation.
“I really believe that just like the 20th century was the era of the bit and the digital revolution, the 21st century is likely to be remembered as the era of the genome,” he says. “We’re seeing that play out in terms of genomic-based screening and diagnostics emerging, like Illumina’s offerings, but we’re also seeing the emergence of genomic-based medicine.”
DeSouza’s excitement is understandable. Well...
Source: TIME: Health - August 14, 2022 Category: Consumer Health News Authors: John Simons Tags: Uncategorized biztech2030 The Leadership Brief Source Type: news
False Claims About COVID Vax Animal Testing Resurface
(MedPage Today) -- False claims that COVID-19 vaccine trials were halted when animals died in preclinical studies are making the rounds on social media again, according to reports.
The misinformation gained traction in 2021 after Sen. Bob Hall... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 9, 2022 Category: American Health Source Type: news
What to Know About the Monkeypox Drug TPOXX —And Why It ’ s So Hard to Get
Monkeypox, which federal officials declared a public health emergency on August 4, is not as contagious as the other ongoing public health emergency in the U.S.: COVID-19. Monkeypox primarily spreads through contact with infected skin lesions. Theoretically, containing monkeypox should therefore be more feasible, as long as testing, vaccines, and treatments are accessible. But in reality, the rollouts of all three approaches have faced major challenges. Getting the antiviral drug tecovirimat, also known as TPOXX, is particularly difficult.
Here’s what to know about the antiviral drug treatment TPOXX.
What is TPOXX?
T...
Source: TIME: Health - August 9, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate monkeypox Source Type: news
Your monkeypox questions answered as vaccine access expands
Editor's note:This story was originally published July 25 onUCLA Health's Connect blog. It was updated Aug. 2.As monkeypox spreads across the United States, there are now documented cases in Los Angeles County. As of July 25, there were 162 confirmed cases in Los Angeles County and at least 3,400 cases in the United States, prompting fears of another coronavirus-style outbreak.Monkeypox, however, is an entirely different virus. It is not a respiratory illness like COVID-19, notes Dr. Omai Garner, director of clinical microbiology for UCLA Health.“It’s a different disease and it’s not the kind of thing that trans...
Source: UCLA Newsroom: Health Sciences - August 3, 2022 Category: Universities & Medical Training Source Type: news
How the Monkeypox Virus Does —and Doesn ’ t —Spread
Until recently, monkeypox rarely spread from person to person. In 2005, a study declared a cluster of six cases in the Republic of Congo “the longest uninterrupted chain of human monkeypox fully documented to date.”
That has changed, to say the least. So far this year, more than 25,000 monkeypox cases have been recorded across 83 countries—and human-to-human transmission is clearly happening at large scale.
How does monkeypox spread among people? Research is ongoing, and findings around monkeypox transmission may develop over time. But here’s what the latest science suggests.
[time-brightcove not-tg...
Source: TIME: Health - August 3, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate monkeypox Source Type: news
Janssen Announces New Data Supporting Safety and Efficacy of RYBREVANT ® and Lazertinib Combination for Patients with Non-Small Cell Lung Cancer and EGFR Mutations
July 26, 2022 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 1b/2 CHRYSALIS-2 study (NCT04077463) cohort evaluating the safety and tolerability of the combination of RYBREVANT® (amivantamab-vmjw) with the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) lazertinib and platinum-based chemotherapy (carboplatin and pemetrexed) in patients with relapsed/refractory non-small cell lung cancer (NSCLC) and EGFR mutations.[1] These findings and additional updates, including data on RYBREVANT® in combination with laze...
Source: Johnson and Johnson - July 26, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
What You Need to Know About Monkeypox
On July 23, following months of rising case counts in numerous countries, the World Health Organization’s (WHO) director-general Tedros Adhanom Ghebreyesus declared monkeypox a global health emergency. That label is meant to prompt a coordinated global response, with the aim of getting the virus’ spread under control.
After that development on the global scale, you may be wondering what the monkeypox outbreak means for your own health. “This is an infection that we need to be aware of,” says Dr. Roy Gulick, chief of infectious disease at Weill Cornell Medicine and NewYork-Presbyterian. “But pe...
Source: TIME: Health - July 25, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Disease healthscienceclimate Source Type: news
World Health Organization Declares Monkeypox a Global Emergency
LONDON — The World Health Organization said the expanding monkeypox outbreak in more than 70 countries is an “extraordinary” situation that now qualifies as a global emergency, a declaration Saturday that could spur further investment in treating the once-rare disease and worsen the scramble for scarce vaccines.
WHO Director-General Tedros Adhanom Ghebreyesus made the decision to issue the declaration despite a lack of consensus among members of WHO’s emergency committee. It was the first time the chief of the U.N. health agency has taken such an action.
“In short, we have an outbreak that has...
Source: TIME: Health - July 23, 2022 Category: Consumer Health News Authors: Time Tags: Uncategorized wire Source Type: news
